Posted On: 07/19/2015 9:32:08 PM
Post# of 1456
March 26, 2014 More Mr Short, he was in a position to do great damage
HempTech Corp, a FutureWorld subsidiary, announces today that on March 21st, 2014, the Company has selected Mr. Bill Short as Product Development Executive to head the development of new products, product joint ventures and product acquisition for HempTechRx, a division of HempTech Corp. HempTechRx’s development & acquisition strategy will be geared toward developing, negotiating joint ventures, leasing, and acquiring hemp and legal medical marijuana products worldwide. Negotiating use agreements with hemp farming companies, medical marijuana dispensaries, and potency & quality control labs will be a key factor in success. With thousands of Farms, Pharmaceutical, Nutraceutical, Pharmacies & dispensaries, popping up worldwide, the Company sees great opportunity to be part of the vertically integration in Hemp and Legal Medical Marijuana transactions from “Seed to sale”.
Mr. Short worked as a pharmaceutical representative of King Pharmaceuticals and Wyeth Pharmaceuticals. He has dealt directly on the front lines of
HempTech Corp, a FutureWorld subsidiary, announces today that on March 21st, 2014, the Company has selected Mr. Bill Short as Product Development Executive to head the development of new products, product joint ventures and product acquisition for HempTechRx, a division of HempTech Corp. HempTechRx’s development & acquisition strategy will be geared toward developing, negotiating joint ventures, leasing, and acquiring hemp and legal medical marijuana products worldwide. Negotiating use agreements with hemp farming companies, medical marijuana dispensaries, and potency & quality control labs will be a key factor in success. With thousands of Farms, Pharmaceutical, Nutraceutical, Pharmacies & dispensaries, popping up worldwide, the Company sees great opportunity to be part of the vertically integration in Hemp and Legal Medical Marijuana transactions from “Seed to sale”.
Mr. Short worked as a pharmaceutical representative of King Pharmaceuticals and Wyeth Pharmaceuticals. He has dealt directly on the front lines of
(0)
(0)
